Update: COVID-19 Clinical Trials Review Committee Approval Required
ACTRI COVID-19 Research Biobank
海豚加速器白金破解版下载
I am delighted to announce that the Altman Clinical and Translational Research Institute (ACTRI) has received a renewal of our five-year Clinical and Translational Science Award (CTSA) totaling approximately $55 million from the National Center for Advancing Translational Science (NCATS), and brings our total support since the inception of the ACTRI to approximately $144 million.
More
ios免费加速器推荐
-
UC BRAID Collaborations Work to Impact Health throughout California
-
Mark Wallace receives NIH funding California Clinical and Translational Research Consortium
-
ResearchCompass for clinical trials support, management, training and resources is now available
-
New Website Helps Researchers Identify and Address Health Disparities
ios免费加速器推荐
-
ACTRI Seeks Applications for KL2 Training Support for Junior Faculty